14-3-3σ positively regulates p53 and suppresses tumor growth

Molecular and Cellular Biology

Volumn 23, Issue 20, 2003, Pages 7096-7107

  Yang, Heng Yin ^a   Wen, Yu Ye ^a,b   Chen, Chih Hsin ^a   Lozano, Guillermina ^a,b   Lee, Mong Hong ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; DOXORUBICIN; LUCIFERASE; PROTEIN 14 3 3; PROTEIN 14 3 3SIGMA; PROTEIN MDM2; PROTEIN P53; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CARCINOGENICITY; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; OLIGOMERIZATION; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; BLOTTING, NORTHERN; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL LINE, TUMOR; CELL NUCLEUS; DNA DAMAGE; DOWN-REGULATION; DOXYCYCLINE; EXONUCLEASES; FEMALE; GENES, REPORTER; GLUTATHIONE TRANSFERASE; HUMANS; LUCIFERASES; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASMS; NIH 3T3 CELLS; PRECIPITIN TESTS; PROTEIN BINDING; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

ANIMALIA; MUS MUSCULUS;

EID: 0141529779     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.20.7096-7107.2003     Document Type: Article

References (48)

1. Aitken, A. 1995. 14-3-3 proteins on the MAP. Trends Biochem. Sci. 20:95-97.
2. Boyd, S. D., K. Y. Tsai, and T. Jacks. 2000. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell Biol. 2:563-568.
3. Chan, T. A., H. Hermeking, C. Lengauer, K. W. Kinzler, and B. Vogelstein. 1999. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 401:616-620.
4. Chene, P. 2001. p53 as a drug target in cancer therapy. Expert Opin. Ther. Patents 11:923-935.
5. Clark, P. A., S. Llanos, and G. Peters. 2002. Multiple interacting domains contribute to p14ARF mediated inhibition of Mdm2. Oncogene 21:4498-4507.
6. Dellambra, E., O. Golisano, S. Bondanza, E. Siviero, P. Lacal, M. Molinari, S. D'Atri, and M. De Luca. 2000. Downregulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes. J. Cell Biol. 149:1117-1130.
7. Dellambra, E., M. Patrone, B. Sparatore, A. Negri, F. Ceciliani, S. Bondanza, F. Molina, F. D. Cancedda, and M. De Luca. 1995. Stratifin, a keratinocyte specific 14-3-3 protein, harbors a pleckstrin homology (PH) domain and enhances protein kinase C activity. J. Cell Sci. 108:3569-3579.
8. Dhar, S., J. A. Squire, M. P. Hande, R. J. Wellinger, and T. K. Pandita. 2000. Inactivation of 14-3-3σ influences telomere behavior and ionizing radiation-induced chromosomal instability. Mol. Cell Biol. 20:7764-7772.
9. Ferguson, A. T., E. Evron, C. B. Umbricht, T. K. Pandita, T. A. Chan, H. Hermeking, J. R. Marks, A. R. Lambers, P. A. Futreal, M. R. Stampfer, and S. Sukumar. 2000. High frequency of hypermethylation at the 14-3-3σ locus leads to gene silencing in breast cancer. Proc. Natl. Acad. Sci. USA 97:6049-6054.
10. Fu, H., R. R. Subramanian, and S. C. Masters. 2000. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40:617-647.
11. Geyer, R. K., Z. K. Yu, and C. G. Maki. 2000. The Mdm2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2:569-573.
12. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
13. 2/M progression. Mol. Cell 1:3-11.
14. Ichimura, T., M. Ito, C. Itagaki, M. Takahashi, T. Horigome, S. Omata, S. Ohno, and T. Isobe. 1997. The 14-3-3 protein binds its target proteins with a common site located towards the C-terminus. FEBS Lett. 413:273-276.
15. Iwata, N., H. Yamamoto, S. Sasaki, F. Itoh, H. Suzuki, T. Kikuchi, H. Kaneto, S. Iku, I. Ozeki, Y. Karino, T. Satoh, J. Toyota, M. Satoh, T. Endo, and K. Imai. 2000. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3σ gene in human hepatocellular carcinoma. Oncogene 19:5298-5302.
16. Jackson, M. W., and S. J. Berberich. 2000. MdmX protects p53 from Mdm2-mediated degradation. Mol. Cell. Biol. 20:1001-1007.
17. Jackson, M. W., M. S. Lindstrom, and S. J. Berberich. 2001. MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation. J. Biol. Chem. 276:25336-25341.
18. Jones, D. H., S. Ley, and A. Aitken. 1995. Isoforms of 14-3-3 protein can form homo- and heterodimers in vivo and in vitro: implications for function as adapter proteins. FEBS Lett. 368:55-58.
19. Kistner, A., M. Gossen, F. Zimmermann, J. Jerecic, C. Ullmer, H. Lubbert, and H. Bujard. 1996. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93:10933-10938.
20. Kumagai, A., and W. G. Dunphy. 1999. Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes Dev. 13:1067-1072.
21. Laronga, C., H. Y. Yang, C. Neal, and M. H. Lee. 2000. Association of the cyclin-dependent kinases and 14-3-3σ negatively regulates cell cycle progression. J. Biol. Chem. 275:23106-23112.
22. Lee, M. H., I. Reynisdottir, and J. Massague. 1995. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9:639-649.
23. Lopez-Girona, A., B. Furnari, O. Mondesert, and P. Russell. 1999. Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397:172-175.
24. Lozano, G., and R. Montes de Oca Luna. 1998. Mdm2 function. Biochim. Biophys. Acta 1377:M55-M59.
25. McLure, K. G., and P. W. Lee. 1998. How p53 binds DNA as a tetramer. EMBO J. 17:3342-3350.
26. Melis, R., and R. White. 1999. Characterization of colonic polyps by two-dimensional gel electrophoresis. Electrophoresis 20:1055-1064.
27. Midgley, C. A., J. M. Desterro, M. K. Saville, S. Howard, A. Sparks, R. T. Hay, and D. P. Lane. 2000. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19:2312-2323.
28. Nigro, J. M., S. J. Baker, A. C. Preisinger, J. M. Jessup, R. Hostetter, K. Cleary, S. H. Bigner, N. Davidson, S. Baylin, P. Devilee, et al. 1989. Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708.
29. Ostergaard, M., H. H. Rasmussen, H. V. Nielsen, H. Vorum, T. F. Orntoft, H. Wolf, and J. E. Celis. 1997. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res. 57:4111-4117.
30. Ouchi, T., A. N. Monteiro, A. August, S. A. Aaronson, and H. Hanafusa. 1998. BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. USA 95:2302-2306.
31. Pan, S., P. C. Sehnke, R. J. Ferl, and W. B. Gurley. 1999. Specific interactions with TBP and TFIIB in vitro suggest that 14-3-3 proteins may participate in the regulation of transcription when part of a DNA binding complex. Plant Cell 11:1591-1602.
32. Pomerantz, J., N. Schreiber-Agus, N. J. Liegeois, A. Silverman, L. Alland, L. Chin, J. Potes, K. Chen, I. Orlow, H. W. Lee, C. Cordon-Cardo, and R. A. DePinho. 1998. The Ink4a tumor suppressor gene product, pl9Arf, interacts with Mdm2 and neutralizes Mdm2's inhibition of p53. Cell 92:713-723.
33. Prasad, G. L., E. M. Valverius, E. McDuffie, and H. L. Cooper. 1992. Complementary DNA cloning of a novel epithelial cell marker protein, Hme1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ. 3:507-513.
34. Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9:1831-1845.
35. Stavridi, E. S., N. H. Chehab, A. Malikzay, and T. D. Halazonetis. 2001. Substitutions that compromise the ionizing radiation-induced association of p53 with 14-3-3 proteins also compromise the ability of p53 to induce cell cycle arrest. Cancer Res. 61:7030-7033.
36. Stommel, J. M., N. D. Marchenko, G. S. Jimenez, U. M. Moll, T. J. Hope, and G. M. Wahl. 1999. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by nuclear export signal masking. EMBO J. 18:1660-1672.
37. Suzuki, H., F. Itoh, M. Toyota, T. Kikuchi, H. Kakiuchi, and K. Imai. 2000. Inactivation of the 14-3-3σ gene is associated with 5′ CpG island hypermethylation in human cancers. Cancer Res. 60:4353-4357.
38. Tzivion, G., Y. H. Shen, and J. Zhu. 2001. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20:6331-6338.
39. Vellucci, V. F., F. J. Germino, and M. Reiss. 1995. Cloning of putative growth regulatory genes from primary human keratinocytes by subtractive hybridization. Gene 166:213-220.
40. Wang, J., H. M. Goodman, and H. Zhang. 1999. An arabidopsis 14-3-3 protein can act as a transcriptional activator in yeast. FEBS Lett. 443:282-284.
41. Wang, W., and D. C. Shakes. 1996. Molecular evolution of the 14-3-3 protein family. J. Mol. Evol. 43:384-398.
42. Waterman, M. J., E. S. Stavridi, J. L. Waterman, and T. D. Halazonetis. 1998. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19:175-178.
43. Xiao, B., S. J. Smerdon, D. H. Jones, G. G. Dodson, Y. Soneji, A. Aitken, and S. J. Gamblin. 1995. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 376:188-191.
44. Yang, H. Y., R. Shao, M. C. Hung, and M. H. Lee. 2001. p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis. Oncogene 20:3695-3702.
45. Yang, H. Y., B. P. Zhou, M. C. Hung, and M. H. Lee. 2000. Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27. J. Biol. Chem. 275:24735-24739.
46. Zhang, Y., Y. Xiong, and W. G. Yarbrough. 1998. ARF promotes Mdm2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725-734.
47. Zhou, B. P., M. C. Hu, S. A. Miller, Z. Yu, W. Xia, S. Y. Lin, and M. C. Hung. 2000. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. J. Biol. Chem. 275:8027-8031.
48. Zhou, B. P., Y. Liao, W. Xia, Y. Zou, B. Spohn, and M. C. Hung. 2001. HER-2/neu induces p53 ubiquitination via Akt-mediated Mdm2 phosphorylation. Nat. Cell Biol. 3:973-982.